1-1 of 1
Donald Harvey, Pharm.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Trial of SNS-032, a Potent and Specific CDK 2, 7 and 9 Inhibitor, in Chronic Lymphocytic Leukemia and Multiple Myeloma

William G. Wierda, MD, R. Chen, MD, William Plunkett, MD, Steven Coutre, MD, Ashraf Z. Badros, MD, Leslie Popplewell, MD, David Siegel, MD, Rajni Sinha, MD, Donald Harvey, Pharm.D., Judith Fox, PhD, Kristi Mahadocon, Peggy Kegley, Mary G. Bolton, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3178.
https://doi.org/10.1182/blood.V112.11.3178.3178
Published: 2008